These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7895533)
21. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Hsueh W; Sun X; Rioja LN; Gonzalez-Crussi F Immunology; 1990 Jul; 70(3):309-14. PubMed ID: 2379939 [TBL] [Abstract][Full Text] [Related]
22. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121 [TBL] [Abstract][Full Text] [Related]
23. Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture. McMasters KM; Peyton JC; Hadjiminas DJ; Cheadle WG Cytokine; 1994 Sep; 6(5):530-6. PubMed ID: 7827289 [TBL] [Abstract][Full Text] [Related]
24. Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo. Adi S; Pollock AS; Shigenaga JK; Moser AH; Feingold KR; Grunfeld C J Clin Invest; 1992 May; 89(5):1603-9. PubMed ID: 1569198 [TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin. Ferguson-Chanowitz KM; Katocs AS; Pickett WC; Kaplan JB; Sass PM; Oronsky AL; Kerwar SS J Infect Dis; 1990 Nov; 162(5):1081-6. PubMed ID: 2230235 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Galanos C; Freudenberg MA Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. Bauldry SA; McCall CE; Cousart SL; Bass DA J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897 [TBL] [Abstract][Full Text] [Related]
28. Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappaB alterations not present in C3H/HeJ mice. West MA; Clair L; Kraatz J; Rodriguez JL J Trauma; 2000 Aug; 49(2):298-305. PubMed ID: 10963543 [TBL] [Abstract][Full Text] [Related]
29. Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response. Yasuda S; Nagaki M; Moriwaki H J Endotoxin Res; 2002; 8(4):253-61. PubMed ID: 12230915 [TBL] [Abstract][Full Text] [Related]
30. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice. Tiegs G; Niehörster M; Wendel A Biochem Pharmacol; 1990 Sep; 40(6):1317-22. PubMed ID: 2403385 [TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Quinn JV; Slotman GJ Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269 [TBL] [Abstract][Full Text] [Related]
32. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension. Xie J; Joseph KO; Bagby GJ; Giles TD; Greenberg SS Am J Physiol; 1997 Jul; 273(1 Pt 2):H164-74. PubMed ID: 9249487 [TBL] [Abstract][Full Text] [Related]
33. Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Sun XM; Qu XW; Huang W; Granger DN; Bree M; Hsueh W Am J Physiol; 1996 Jan; 270(1 Pt 1):G184-90. PubMed ID: 8772517 [TBL] [Abstract][Full Text] [Related]
34. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577 [TBL] [Abstract][Full Text] [Related]
35. Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells. Camussi G; Biancone L; Iorio EL; Silvestro L; Da Col R; Capasso C; Rossano F; Servillo L; Balestrieri C; Tufano MA Kidney Int; 1992 Dec; 42(6):1309-18. PubMed ID: 1335527 [TBL] [Abstract][Full Text] [Related]
36. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560 [TBL] [Abstract][Full Text] [Related]
37. Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran. Yuan Q; Zhao F; Chung SW; Fan P; Sultzer BM; Kan YW; Wong PM Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2852-7. PubMed ID: 10706609 [TBL] [Abstract][Full Text] [Related]
38. Association of prostacyclin production with resistance of C3H/HeJ mice to endotoxin shock. Walker RI; Casey LC; Ramwell PW; Fletcher JR Adv Shock Res; 1982; 7():125-32. PubMed ID: 6753526 [TBL] [Abstract][Full Text] [Related]
39. Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice. Myers AK; Robey JW; Price RM Br J Pharmacol; 1990 Mar; 99(3):499-502. PubMed ID: 2110016 [TBL] [Abstract][Full Text] [Related]
40. Endogenous bacterial toxins are required for the injurious action of platelet-activating factor in rats. Sun XM; MacKendrick W; Tien J; Huang W; Caplan MS; Hsueh W Gastroenterology; 1995 Jul; 109(1):83-8. PubMed ID: 7797043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]